Pimavanserin;1-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea;Pimavamserin;1-[(4-fluorophenyl)Methyl]-1-(1-Methylpi;ACP103;ACP-103;N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-isobutoxybenzyl)carbamide;N-(4-Fluorobenzyl)-N-(1-Methylpiperidin-4-yl)-N'-[[4-(2-Methylpropyloxy)phenyl]Methyl]carbaMide;N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide;N-[(4-Fluorophenyl)Methyl]-N-(1-Methyl-4-piperidinyl)-N'-[[4-(2-Methylpropoxy)phenyl]Methyl]urea;Unii-jz963p0dik;Pimavanserin [INN];JZ963P0DIK;706779-91-1 (free base);N05AX17;NCGC00390656-01;NS00071545;N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide;EN300-19659487;pimavanserinum;HMS3742A03;NCGC00390656-02;A836958;PIMAVANSERIN [WHO-DD];BCP11618;AKOS015902593;pimavanserine;N-[(4-Fluorophenyl)methyl]-N-(1-methyl-4-piperidinyl)-N'-[[4-(2-methylpropoxy)phenyl]methyl]-urea; N-(4-Fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-[[4-(2-methylpropyloxy)phenyl]methyl]carbamide; Pimavanserin;DTXSID90990906;SB16963;N-[(4-Fluorophenyl)Methyl]-N-(1-Methyl-4-piperidinyl)-N'-[[4-(2-Methylpropoxy)phenyl]Methyl]urea;;Pimavanserin(ACP-103);Q7194603;PIMAVANSERIN [MI];HY-14557;GTPL8423;J-503297;ME-0240;1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea;CHEBI:133017;706779-91-1;Nuplazid (proposed trade name);CS-3378;SCHEMBL675165;BDBM139370;1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-{[4-(2-methylpropoxy)phenyl]methyl}urea;UNII-JZ963P0DIK;Pimavanserin free base;N-((4-fluorophenyl)methyl)-N-(1-methylpiperidin-4-yl)-N'-((4-(2-methylpropoxy)phenyl)methyl)urea;706782-28-7;CHEMBL2111101;Pimanavserin;RKEWSXXUOLRFBX-UHFFFAOYSA-N;EX-A4895;AC-5273;methyltrimethylacetate;DB05316;FT-0653701;N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide;pimavanserina;N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea